ice9

I do quantitative things. Sometimes I think about society and economics.

[ice9 @__ice9]

https://t.co/5CTDaUX650

[ice9 @__ice9]

@Pravduh15 It's a point about hospital treatments.

[ice9 @__ice9]

Informed consent is a thing.

Most people facing a potentially crippling or lethal illness have a much greater risk tolerance against 'well maybe item 6 of 11 didn't do much to help here in retrospect' than you likely think.

That already happens often in routine practice anyway!

[ice9 @__ice9]

Again, the most useful points for a broad audience:

- get vaccine ASAP; prefer mRNA or Novavax; 2 doses far better than 1

- store RCT-validated early treatments: bromhexine-or-ambroxol + nitazoxanide-or-niclosamide, fluvoxamine, ivermectin

- N100 masks

https://t.co/DmV3mQOxPL

[ice9 @__ice9]

Remembered: badly needed to link the dual entry inhibition thread; people keep not recalling what it is.

Basically--

One of:
- bromhexine
- ambroxol
- maybe-camostat (but highest dose needed...)
And:
- Nitazoxanide
- Niclosamide
- RCT: HCQ (sry but yes)

https://t.co/DyxrurwEVg

[ice9 @__ice9]

If in doubt, *ask the patient*.

People have a fundamental right to participate in their own health-- *they already do so 99% of the time anyway*.

'This might help with X; it's a bit less certain; may cause Y side effects; studies say usually well-tolerated; do you want to try?'

[ice9 @__ice9]

@aptlyamphoteric the ride never ends 🙃

[Eric Topol @EricTopol]

Reuse of N95 and related masks, a review of 42 studies
https://t.co/PqnC5kzlrW
Comparison of merits of 5 different methods for retaining filtration
https://t.co/PqnC5kzlrW
@JAMA_current by @MSchumm90 and colleagues @UCLAHealth 😷

[ice9 @__ice9]

Current COVID-19 national vaccine coverage scoreboard--

https://t.co/ILtv2uewcX

[ice9 @__ice9]

@dronico Such marketing gloss.

https://t.co/hyYM0lWha2

[ice9 @__ice9]

Efficacy is nowhere near Novavax or the mRNA options (Pfizer/Moderna).

Much like Sinovac/Sinopharm(/CanSino), the tell for this is the headline numbers focusing solely on severe COVID-19 and ignoring mild/moderate cases.

[Eric Topol @EricTopol]

The prototype and story of a #LongCovid individual: young, healthy and mild illness
https://t.co/Agynu0FRhp
@LancetRespirMed

[ice9 @__ice9]

If Marshall or Jenner ran their now famous experiments today, they would likely be written off as curiosities.

[ice9 @__ice9]

@mistman78 @__ice9_2 ongoing one

[ice9 @__ice9]

@DrHaroldChang @__ice9_2 bitcoin

[ice9 @__ice9_2]

This truly is the time of the cicadas.

Every strategy with merit deserves its own time in the sun.

🌥️🌤️☀️

📈

Or moonlight, clandestine economy, filling gaps even at edges, choke points.

🌑🌒🌓🌔🌕🎴

Sometimes even spectacular.

Fly....

☄️

Glory to the forgetful.

⏳⌛

[ice9 @__ice9]

The continued failure to trial or use ITPP in critical care is an indictment against the regulatory and productive institutions of our supposedly-advanced (increasingly just shorthand for 'gridlocked') economy.

https://t.co/Jw64FfUtvA

It makes blood transport oxygen better.

[ice9 @__ice9]

By the way I wrote that wiki article too.

No one else was doing it.

Someone had to stand up.

[ice9 @__ice9]

The continued failure to trial or use ITPP in critical care is an indictment against the regulatory and productive institutions of our supposedly-advanced (increasingly just shorthand for 'gridlocked') economy.

https://t.co/Jw64FfUtvA

It makes blood transport oxygen better.

[ice9 @__ice9]

@patrickc @balajis

If you want a real impact in reducing ICU deaths, look into ITPP, while doing cyproheptadine and fluvoxamine.

Yes I know I am terrible with DMs.

Yes I know I am handicapped by pseudonymity. I will never use WhatsApp.

Just do it. My issues are irrelevant.